Apollomics (APLM) Assets (2021 - 2025)
Apollomics' (APLM) quarterly Assets came in at $6.7 million in Q4 2025, down 48.74% year-over-year from $13.1 million in Q4 2024, and down 39.62% quarter-over-quarter from $11.1 million in Q2 2025.
Analysis
Apollomics (APLM) Assets (2021 - 2025) Analysis & Trends
Apollomics (APLM) has reported Assets for 5 consecutive years, with $6.7 million the latest figure, recorded in Q4 2025.
- On a quarterly basis, Assets fell 48.74% year-over-year to $6.7 million in Q4 2025; TTM through Dec 2025 was $6.7 million, a 48.74% decrease from a year earlier, with the FY2025 full-year figure at $6.7 million, down 48.74% from the prior year.
- Assets was $6.7 million for Q4 2025 at Apollomics, down from $11.1 million in the prior quarter.
- Over five years, Assets peaked at $123.4 million in Q4 2021 and troughed at $6.7 million in Q4 2025.
- A 5-year average of $43.9 million and a median of $24.7 million in 2023 frame the typical range for Assets.
- Across the five-year window, Assets tumbled 80.7% in 2023 and retreated 11.24% in 2024, its largest moves.
- Over 5 years, Assets stood at $123.4 million in 2021, then slumped by 38.05% to $76.5 million in 2022, then plunged by 80.7% to $14.8 million in 2023, then fell by 11.24% to $13.1 million in 2024, then plunged by 48.74% to $6.7 million in 2025.
- The last three Assets figures came in at $6.7 million (Q4 2025), $11.1 million (Q2 2025), and $13.1 million (Q4 2024), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Amgen | 206.44 Bn | 192.45 Bn | 7.24 Bn | 95.64 Bn |
| 2 | Gilead Sciences | 179.97 Bn | 176.79 Bn | 6.22 Bn | 49.36 Bn |
| 3 | Vertex Pharmaceuticals | 130.57 Bn | 122.72 Bn | 2.84 Bn | 27.42 Bn |
| 4 | Regeneron Pharmaceuticals | 81.63 Bn | 73.63 Bn | 3.93 Bn | 41.73 Bn |
| 5 | Argenx Se | 60.34 Bn | 55.16 Bn | 1.37 Bn | 10.03 Bn |
| 6 | Moderna | 54.37 Bn | 49.23 Bn | 52.00 Mn | 10.96 Bn |
| 7 | Alnylam Pharmaceuticals | 33.07 Bn | 29.76 Bn | 992.69 Mn | 5.56 Bn |
| 8 | Biogen | 31.84 Bn | 30.55 Bn | 1.96 Bn | 32.09 Bn |
| 9 | Roivant Sciences | 29.49 Bn | 29.49 Bn | 1.16 Mn | 5.31 Bn |
| 10 | Apollomics | 34.50 Mn | 31.23 Mn | - | 6.71 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2025 | 6.71 Mn |
| Jun 30, 2025 | 11.12 Mn |
| Dec 31, 2024 | 13.10 Mn |
| Jun 30, 2024 | 34.57 Mn |
| Dec 31, 2023 | 14.76 Mn |
| Jun 30, 2023 | 71.38 Mn |
| Dec 31, 2022 | 76.48 Mn |
| Dec 31, 2021 | 123.44 Mn |